ADvantage Therapeutics
Operator of a pharmaceutical company intended to develop therapeutics for patients suffering from neurodegenerative disease. The company specializes in developing therapies to treat Alzheimer's Diseas...
Interested in buying or selling ADvantage Therapeutics shares?
Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.
Valuation
$81M
Market implied
Share Price
N/A
Total Raised
$18.7M
Last Round
N/A